Related Experiment Video

Updated: Feb 8, 2026

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells
08:42

Dextran Enhances the Lentiviral Transduction Efficiency of Murine and Human Primary NK Cells

Published on: January 15, 2018

11.7K

Enhanced Cancer Immunotherapy with Smad3-Silenced NK-92 Cells

Qing-Ming Wang1,2, Patrick Ming-Kuen Tang1,3, Guang-Yu Lian1

  • 1Li Ka Shing Institute of Health Sciences, Department of Medicine & Therapeutics, and Lui Che Woo Institute of Innovative Medicine, The Chinese University of Hong Kong, Hong Kong SAR, China.

Cancer Immunology Research
|June 20, 2018
PubMed

Insights

Silencing SMAD3 in natural killer (NK) cells enhances their cancer-killing ability by boosting interferon-gamma (IFNγ) production, offering a promising new avenue for cancer immunotherapy.

Area of Science:

  • Immunology
  • Cancer Biology
  • Cell Therapy

Background:

  • Natural killer (NK) cells are crucial for early anticancer immunity.
  • Tumor cells produce TGFβ1, which suppresses NK cell activity via Smad3.
  • The tumor microenvironment often inhibits NK cell development and function.

Purpose of the Study:

  • To develop a SMAD3-silencing NK cell line for enhanced cancer immunotherapy.
  • To investigate the mechanism by which SMAD3 silencing affects NK cell function.
  • To evaluate the efficacy of the engineered NK cells in preclinical cancer models.

Main Methods:

  • Genetic engineering to create a stable SMAD3-silencing human NK cell line (NK-92-S3KD).
  • Assessment of NK cell activity and cytokine production under TGFβ1-rich conditions.
  • Analysis of gene expression, including IFNG as an E4BP4 target.
  • Evaluation of NK-92-S3KD immunotherapy in human hepatoma and melanoma xenograft mouse models.

Main Results:

  • NK-92-S3KD cells showed significantly enhanced cancer-killing activity and cytokine production compared to parental cells in the presence of TGFβ1.
  • SMAD3 silencing led to E4BP4 upregulation, which promoted interferon-γ (IFNγ) production.
  • Immunotherapy with NK-92-S3KD cells increased IFNγ, granzyme B, and perforin levels within tumors.
  • Tumor progression was inhibited in xenograft models treated with NK-92-S3KD cells.

Conclusions:

  • SMAD3 silencing is a viable strategy to overcome TGFβ1-mediated NK cell suppression.
  • The engineered NK-92-S3KD cell line demonstrates potent anti-cancer activity through enhanced cytokine and cytotoxic molecule production.
  • NK-92-S3KD cells hold potential for clinical application in cancer immunotherapy.

More Related Videos

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins07:20

Generation of Knock-out Primary and Expanded Human NK Cells Using Cas9 Ribonucleoproteins

Published on: June 14, 2018

13.1K
Flow Cytometry-based Assay for the Monitoring of NK Cell Functions08:17

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

22.0K

Related Concept Videos

Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
8.8K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
2.0K
Self-Evaluation: Self-Enhancement and Self-Verification03:00

Self-Evaluation: Self-Enhancement and Self-Verification

Social psychologists have documented that feeling good about ourselves and maintaining positive self-esteem is a powerful motivator of human behavior (Tavris & Aronson, 2008). In the United States, members of the predominant culture typically think very highly of themselves and view themselves as good people who are above average on many desirable traits (Ehrlinger, Gilovich, & Ross, 2005). Often, our behavior, attitudes, and beliefs are affected when we experience a threat to our...
5.8K
Bioavailability Enhancement: Drug Solubility Enhancement01:16

Bioavailability Enhancement: Drug Solubility Enhancement

Body:Bioavailability is a critical factor in determining a drug's effectiveness. It refers to the proportion of a drug that enters the circulation when introduced into the body and is, as a result, able to have an active effect. Enhancing bioavailability is essential for drugs with poor solubility, as it can significantly impact their therapeutic efficacy. Various methods are employed to increase the solubility of drugs, thereby enhancing their bioavailability.Micronization and nanonization are...
266
Bioavailability Enhancement: Drug Permeability Enhancement01:27

Bioavailability Enhancement: Drug Permeability Enhancement

Body:After oral administration, poor permeability often limits the rate at which drugs are absorbed through the intestinal epithelium. Enhancing drug permeability is crucial for effective therapy, and several strategies have been developed to overcome this challenge.One effective strategy involves the use of lipid-based formulations. These formulations enhance dissolution and solubility, targeting physiological mechanisms to increase drug absorption. This includes stimulating bile salt...
211
Cancer Cell Migration through Invadopodia01:35

Cancer Cell Migration through Invadopodia

Invadosome is a broad category of cell surface structures with proteolytic activity that  degrades the extracellular matrix (ECM). Invadosomes are present in normal cell types, including macrophages, endothelial cells, and neurons, as well as tumor cells. Although the macrophage podosomes and tumor cell invadopodia are classified as invadosomes, they have different structures, molecular pathways, and functions. Podosomes are short structures that last for a few minutes. However,...
3.3K